MJNA (Medical Marijuana) LT-Debt-to-Total-Asset: 0.05 (As of Dec. 2017)


What is Medical Marijuana LT-Debt-to-Total-Asset?

Medical Marijuana MJNA -50.00% LT-Debt-to-Total-Asset is 0.05 as of Dec. 2017.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Medical Marijuana's long-term debt to total assests ratio for the quarter that ended in Dec. 2017 was 0.05.

Medical Marijuana's long-term debt to total assets ratio increased from Dec. 2015 (0.00) to Dec. 2017 (0.05). It may suggest that Medical Marijuana is progressively becoming more dependent on debt to grow their business.

Medical Marijuana  (OTCPK:MJNA) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Medical Marijuana LT-Debt-to-Total-Asset Related Terms

Medical Marijuana LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Medical Marijuana's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Marijuana LT-Debt-to-Total-Asset Chart

Medical Marijuana Annual Data
Trend Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial 0.03 0.15 0.00 0.03 0.05

Medical Marijuana Semi-Annual Data
Dec09 Dec10 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
LT-Debt-to-Total-Asset Get a 7-Day Free Trial 0.03 0.15 0.00 0.03 0.05

Medical Marijuana LT-Debt-to-Total-Asset Calculation

Medical Marijuana's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2017 is calculated as

LT Debt to Total Assets (A: Dec. 2017 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2017 )/Total Assets (A: Dec. 2017 )
=13.432/274.838
=0.05

Medical Marijuana's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2017 is calculated as

LT Debt to Total Assets (Q: Dec. 2017 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2017 )/Total Assets (Q: Dec. 2017 )
=13.432/274.838
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →
What does a LT-Debt-to-Total-Asset of 0.05 mean?
Medical Marijuana (MJNA) has a LT-Debt-to-Total-Asset of 0.05 as of Dec. 2017. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medical Marijuana and its competitors.
Is Medical Marijuana's LT-Debt-to-Total-Asset too high?
Medical Marijuana's current LT-Debt-to-Total-Asset is 0.05.
How does Medical Marijuana's LT-Debt-to-Total-Asset compare to UPC and ERBB?
Medical Marijuana's LT-Debt-to-Total-Asset of 0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?
A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high LT-Debt-to-Total-Asset mean?
A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Medical Marijuana and its competitors. Medical Marijuana's current LT-Debt-to-Total-Asset is 0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Marijuana stock overvalued right now?
Medical Marijuana (MJNA) has a current LT-Debt-to-Total-Asset of 0.05. The current LT-Debt-to-Total-Asset is 0.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is LT-Debt-to-Total-Asset calculated?
LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Medical Marijuana (MJNA), the current LT-Debt-to-Total-Asset is 0.05 as of Dec. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medical Marijuana Business Description

Address 2384 La Mirada Drive, Vista, CA, USA, 92081
Medical Marijuana Inc is engaged in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids, including cannabidiol and other products containing CBD-rich hemp oil. The company's products are used by pharmaceutical, nutraceutical, and cosmeceutical industries. Some of its products are CBD Capsules, CBD Tinctures, Vaporizers, and Hemp foods among others. The company operates through Retail and Wholesale division; Direct Sales division; and Manufacturing and Production Division.